Concepedia

Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer

Francesco Boccardo, A. Rubagotti, Giario Conti, D. Potenzoni, Antonio Manganelli, Demetrio Del Monaco

Cancer Chemotherapy and Pharmacology · 2005 · 16 citations · 7 references

DOI

Concepts

References

7

Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program

William A. See, Manfred P. Wirth, David G. McLeod et al. · The Journal of Urology · 2002 · 229 citations

, , +11

BICALUTAMIDE 150 MG IN ADDITION TO STANDARD CARE IN PATIENTS WITH LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM THE SECOND ANALYSIS OF THE EARLY PROSTATE CANCER PROGRAM AT MEDIAN FOLLOWUP OF 5.4 YEARS

Manfred P. Wirth, William A. See, David G. McLeod et al. · The Journal of Urology · 2004 · 209 citations

, , +13

The bicalutamide Early Prostate Cancer Program

W. A. See, D. G. R. McLeod, Peter Iversen et al. · Urologic Oncology Seminars and Original Investigations · 2001 · 66 citations

, , +9

Casodex<sup>TM</sup> 10–200 mg Daily, Used as Monotherapy for the Treatment of Patients with Advanced Prostate Cancer

C. Tyrrell, L. Denis, D.W.W. Newling et al. · European Urology · 1998 · 62 citations

, , +4

Pharmacology and pharmacokinetics of the newer generation aromatase inhibitors.

Aman U. Buzdar · PubMed · 2003 · 53 citations

, , +17